This announcement is a separate document:
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer JACOB GARY S
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.